av/mdxhealth--big.svg

EURONEXT:MDXH

MDxHealth SA

  • Stock

EUR

Last Close

3.14

15/12 16:35

Market Cap

85.63M

Beta: 0.84

Volume Today

14.08K

Avg: 659.51K

PE Ratio

−17.04

PFCF: −3.06

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
average inventory
147.00K
-
515.50K
250.69%
1.14M
121.82%
1.45M
27.07%
1.70M
16.93%
1.86M
9.65%
1.50M
19.51%
1.76M
17.24%
2.12M
20.45%
2.12M
0.07%
average payables
1.64M
-
4.27M
160.93%
5.94M
39.12%
7.08M
19.22%
7.80M
10.21%
7.25M
7.01%
5.71M
21.35%
5.14M
9.93%
6.39M
24.29%
8.82M
38.03%
average receivables
2.57M
-
5.11M
98.78%
9.60M
87.73%
14.90M
55.22%
19.26M
29.28%
19.53M
1.39%
12.91M
33.88%
5.29M
59.00%
4.48M
15.41%
7.21M
60.99%
book value per share
0.82
-
0.68
16.26%
1.07
56.77%
1.14
6.74%
0.87
23.78%
0.90
3.69%
0.32
65.16%
0.07
77.70%
0.38
447.10%
0.06
84.60%
capex per share
-0.04
-
-0.04
4.70%
-0.05
31.84%
-0.11
108.29%
-0.10
8.16%
-0.02
76.02%
-0.00
95.00%
-0.01
453.30%
-0.01
13.85%
-0.03
260.16%
capex to depreciation
-2.91
-
-4.03
38.42%
-2.38
40.82%
-2.84
19.09%
-2.58
9.27%
-0.46
82.23%
-0.02
95.34%
-0.16
655.04%
-0.30
83.12%
-0.85
187.35%
capex to operating cash flow
0.09
-
0.07
15.98%
0.15
101.36%
0.29
101.79%
0.46
57.31%
0.05
89.83%
0.00
93.05%
0.03
709.93%
0.04
49.80%
0.12
207.06%
capex to revenue
-0.16
-
-0.12
27.43%
-0.12
2.89%
-0.16
35.98%
-0.12
26.65%
-0.05
60.44%
-0.01
86.95%
-0.03
371.87%
-0.04
37.84%
-0.11
178.86%
cash per share
0.82
-
0.54
33.84%
0.74
36.00%
0.66
10.46%
0.34
49.08%
0.45
34.91%
0.35
22.53%
0.19
45.58%
0.48
150.20%
0.10
79.46%
days of inventory on hand
10.77
-
48.64
351.49%
75.43
55.07%
53.43
29.16%
68.65
28.48%
56.60
17.55%
36.47
35.57%
80.61
121.02%
58.98
26.84%
47.62
19.25%
days payables outstanding
206.10
-
297.75
44.47%
349.41
17.35%
272.62
21.98%
288.16
5.70%
202.14
29.85%
151.70
24.95%
184.53
21.64%
230.07
24.68%
208.30
9.47%
days sales outstanding
107.94
-
254.15
135.45%
234.17
7.86%
227.25
2.96%
179.59
20.97%
246.42
37.22%
207.35
15.85%
77.36
62.69%
83.10
7.41%
92.17
10.92%
debt to assets
0.01
-
0.01
45.91%
0.02
90.14%
0.01
46.82%
0.27
3,270.87%
0.50
83.98%
0.21
58.41%
0.33
61.19%
debt to equity
0.02
-
0.01
46.76%
0.02
99.01%
0.01
50.28%
0.56
5,426.76%
2.71
386.46%
0.33
87.78%
4.27
1,187.92%
dividend yield
earnings yield
-0.14
-
-0.08
38.91%
-0.08
7.48%
-0.06
26.01%
-0.06
14.22%
-0.27
312.47%
-0.59
122.13%
-0.33
44.27%
-0.25
23.05%
-0.50
97.13%
enterprise value
95.05M
-
165.96M
74.61%
159.88M
3.67%
203.24M
27.12%
174.50M
14.14%
96.25M
44.84%
61.86M
35.73%
91.00M
47.10%
78.86M
13.34%
124.72M
58.16%
enterprise value over ebitda
-6.19
-
-11.09
79.15%
-11.84
6.75%
-18.27
54.28%
-17.31
5.24%
-3.27
81.13%
-1.55
52.57%
-3.79
144.93%
-3.30
13.02%
-3.78
14.56%
ev to operating cash flow
-6.74
-
-8.96
33.03%
-11.11
23.90%
-12.25
10.33%
-16.64
35.76%
-3.37
79.73%
-2.78
17.70%
-4.49
61.96%
-3.50
22.20%
-3.66
4.53%
ev to sales
12.58
-
14.46
14.91%
9.15
36.69%
6.80
25.66%
4.31
36.69%
3.40
21.15%
5.25
54.53%
4.95
5.64%
3.55
28.41%
3.37
5.08%
free cash flow per share
-0.51
-
-0.57
11.99%
-0.40
30.04%
-0.47
16.60%
-0.31
34.01%
-0.52
68.70%
-0.36
31.12%
-0.25
30.10%
-0.19
23.02%
-0.24
26.58%
free cash flow yield
-0.13
-
-0.11
16.07%
-0.09
18.98%
-0.09
5.80%
-0.08
12.46%
-0.25
204.14%
-0.31
25.13%
-0.23
25.61%
-0.19
15.64%
-0.38
98.03%
graham net net
0.72
-
0.52
27.39%
0.63
21.40%
0.66
3.47%
0.36
45.74%
0.49
37.06%
0.11
77.84%
-0.07
166.41%
0.29
500.81%
-0.55
290.35%
graham number
3.15
-
2.60
17.38%
2.91
11.91%
2.71
6.70%
2.20
18.99%
3.39
54.02%
2.21
34.73%
0.76
65.82%
1.48
95.99%
0.65
55.96%
income quality
0.88
-
1.21
37.49%
1.00
17.06%
1.29
29.00%
0.85
33.81%
0.89
4.06%
0.52
41.94%
0.75
44.56%
0.84
12.55%
0.90
7.16%
intangibles to total assets
0.03
-
0.06
94.60%
0.19
197.88%
0.21
6.62%
0.28
37.77%
0.24
16.52%
0.18
24.61%
0.16
11.26%
0.05
71.07%
0.69
1,400.28%
interest coverage
-29.00
-
-28.22
2.70%
-391.44
1,287.29%
-135.75
65.32%
-20.17
85.15%
-14.32
29.01%
-6.17
56.91%
interest debt per share
0.02
-
0.02
3.63%
0.03
24.11%
0.01
60.06%
0.18
1,614.08%
0.21
14.39%
0.14
30.92%
0.29
104.29%
inventory turnover
33.88
-
7.50
77.85%
4.84
35.51%
6.83
41.17%
5.32
22.17%
6.45
21.28%
10.01
55.20%
4.53
54.75%
6.19
36.68%
7.66
23.84%
invested capital
0.02
-
0.01
46.76%
0.02
99.01%
0.01
50.28%
0.56
5,426.76%
2.71
386.46%
0.33
87.78%
4.27
1,187.92%
market cap
119.73M
-
184.86M
54.40%
189.55M
2.54%
233.20M
23.03%
190.45M
18.33%
121.93M
35.98%
72.91M
40.21%
91.08M
24.92%
121.80M
33.73%
100.43M
17.55%
net current asset value
22.77M
-
20.94M
8.07%
31.17M
48.86%
36.51M
17.14%
24.34M
33.33%
34.50M
41.75%
10.00M
71.01%
-2.92M
129.15%
38.43M
1,418.00%
-80.67M
309.90%
net debt to ebitda
1.61
-
1.26
21.45%
2.20
74.00%
2.69
22.58%
1.58
41.29%
0.87
44.92%
0.28
68.25%
0.00
98.76%
1.80
52,461.14%
-0.74
140.97%
net income per share
-0.54
-
-0.44
18.49%
-0.35
20.11%
-0.29
18.46%
-0.25
13.90%
-0.56
128.79%
-0.69
22.28%
-0.36
47.63%
-0.25
29.79%
-0.32
26.00%
operating cash flow per share
-0.47
-
-0.53
13.43%
-0.35
34.53%
-0.36
3.22%
-0.21
41.62%
-0.50
135.76%
-0.36
28.11%
-0.24
31.68%
-0.18
24.00%
-0.22
17.29%
payables turnover
1.77
-
1.23
30.78%
1.04
14.78%
1.34
28.17%
1.27
5.39%
1.81
42.55%
2.41
33.25%
1.98
17.79%
1.59
19.80%
1.75
10.45%
receivables turnover
3.38
-
1.44
57.53%
1.56
8.54%
1.61
3.05%
2.03
26.54%
1.48
27.12%
1.76
18.84%
4.72
168.03%
4.39
6.90%
3.96
9.84%
research and ddevelopement to revenue
0.21
-
0.06
69.04%
0.12
86.17%
-0.01
109.24%
0.05
505.74%
0.06
41.62%
0.76
1,095.25%
0.25
67.61%
0.30
21.34%
0.20
32.03%
return on tangible assets
-0.57
-
-0.53
7.44%
-0.31
41.04%
-0.25
21.14%
-0.29
19.69%
-0.65
121.49%
-1.29
98.83%
-1.12
13.33%
-0.43
61.50%
-1.35
214.28%
revenue per share
0.25
-
0.33
31.32%
0.42
28.14%
0.65
53.18%
0.81
25.20%
0.49
39.39%
0.19
61.71%
0.22
17.26%
0.18
17.41%
0.24
29.16%
roe
-0.66
-
-0.64
2.66%
-0.33
49.04%
-0.25
23.61%
-0.28
12.97%
-0.62
120.65%
-2.19
250.95%
-5.13
134.78%
-0.66
87.17%
-5.39
718.36%
roic
-0.67
-
-0.64
4.14%
-0.32
50.16%
-0.24
25.49%
-0.27
14.51%
-0.60
120.87%
-1.33
119.43%
-1.16
12.62%
-0.43
62.61%
-0.81
86.66%
sales general and administrative to revenue
0.25
-
0.22
11.82%
0.17
21.82%
0.13
22.19%
0.13
0.04%
0.22
65.24%
0.48
120.53%
0.23
53.12%
0.23
0.91%
0.64
178.82%
shareholders equity per share
0.82
-
0.68
16.26%
1.07
56.77%
1.14
6.74%
0.87
23.78%
0.90
3.69%
0.32
65.16%
0.07
77.70%
0.38
447.10%
0.06
84.60%
stock based compensation to revenue
0.04
-
0.04
7.83%
0.03
34.28%
0.02
23.99%
0.02
22.41%
0.04
52.50%
0.07
108.43%
0.07
4.74%
0.05
22.05%
0.02
57.42%
tangible asset value
23.56M
-
21.77M
7.60%
33.09M
52.02%
38.77M
17.17%
26.91M
30.59%
36.58M
35.93%
12.46M
65.95%
791K
93.65%
43.45M
5,393.17%
-72.78M
267.49%
tangible book value per share
0.78
-
0.63
20.15%
0.80
28.01%
0.84
4.96%
0.54
35.93%
0.63
17.77%
0.20
68.65%
0.01
95.22%
0.36
3,648.10%
-0.46
229.84%
working capital
22.77M
-
21.02M
7.71%
33.82M
60.91%
38.90M
15.00%
26.20M
32.64%
36.39M
38.87%
20.48M
43.71%
10.07M
50.83%
50.17M
398.25%
10.87M
78.33%

All numbers in EUR (except ratios and percentages)